Nestle Increases Health Care Investment With Galderma Control
This article was originally published in The Tan Sheet
Executive Summary
Galderma will be the “foundation” of a new division to be called Nestle Skin Health SA, said Nestle Chairman Peter Brake-Letmathe. L’Oreal will give Nestle its 50% stake in Galderma and $4.6 billion in cash to buy back 8% of its own stock from Nestle.
You may also be interested in...
Nestle Health Grows: Health And Wellness Industry News
Nestle to pay $2.3bn for firm Atrium Innovations, owner of US plant-based supplement marketer Garden of Life and other nutritional brands; Wellness Resources warned on disease claims for omega-3s; and latest health and wellness sector recalls.
Nestle Grows Skin Care Footprint, Valeant Gains Antitrust Cover In Derma Deal
Swiss food and beverage firm Nestle grows its stake in North American skin care with its pending $1.4 billion acquisition from Valeant of five aesthetic dermatology brands, demonstrating its commitment to health and wellness, analysts say. Valeant resolves potential antitrust obstacles to its proposed Allergan acquisition.
Nestle Grows Skin Care Footprint, Valeant Gains Antitrust Cover In Derma Deal
Swiss food and beverage firm Nestle grows its stake in North American skin care with its pending $1.4 billion acquisition from Valeant of five aesthetic dermatology brands, demonstrating its commitment to health and wellness, analysts say. Valeant resolves potential antitrust obstacles to its proposed Allergan acquisition.